Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuefen Gao

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Digestive Diseases (Basel, Switzerland)|November 9, 2022
The Role of Mean Nocturnal Baseline Impedance and Post-Reflux Swallow-Induced Peristaltic Wave Index in the Diagnosis and Treatment of Gastroesophageal Reflux DiseaseSiyu Liao, Jiamin Hao, Jing Zhou, et al.
Gastroenterology Research and Practice|June 25, 2016
The Impact of Colonoscopy Quality Control Table on Adenoma Detection RatesBin Deng, Jiehua Zhi, Yaosheng Chen, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 1, 2023
Urolithin C reveals anti-NAFLD potential via AMPK-ferroptosis axis and modulating gut microbiotaJingyuan Xu, Hongyang Tian, Yajun Ji, et al.
Journal of Gastroenterology and Hepatology|December 8, 2022
The interaction between obesity and visceral hypersensitivityWu Yanping, Xuefen Gao, Yizun Cheng, et al.
BMC Infectious Diseases|February 7, 2023
Study on the prediction effect of a combined model of SARIMA and LSTM based on SSA for influenza in Shanxi Province, ChinaZhiyang Zhao, Mengmeng Zhai, Guohua Li, et al.
BMC Infectious Diseases|December 18, 2025
Efficacy, safety and immunogenicity of a recombinant human papillomavirus bivalent (types 16, 18) vaccine in healthy 18-30-year-old Chinese women: a phase III, double-blind, randomized, controlled trialLiwei Shi, Xuefen Gao, Lili Huang, et al.
Vaccine|April 14, 2025
Corrigendum to "Antibody persistence in Chinese toddlers at 1 year and 2 years after two different 4-dose schedules of a novel 13-valent pneumococcal conjugate vaccine (PCV13-TT)" [Vaccine 49 (7) (2025) 126815]Qiang Ye, Hong Li, Zhiqiang Xie, et al.
Vaccine|February 16, 2025
Antibody persistence in Chinese toddlers at 1 year and 2 years after two different 4-dose schedules of a novel 13-valent pneumococcal conjugate vaccine (PCV13-TT)Qiang Ye, Hong Li, Zhiqiang Xie, et al.
Human Vaccines & Immunotherapeutics|May 27, 2026
Comparison of safety and immunogenicity between high-dose and low-dose quadrivalent influenza vaccines in children aged 6-35 months in China: A randomized, double-blind clinical studyXue Guo, Jingyu Li, Xufeng Dong, et al.
Human Vaccines & Immunotherapeutics|June 17, 2022
Safety and immunogenicity of a quadrivalent, inactivated, split-virion influenza vaccine (IIV4-W) in healthy people aged 3-60 years: a phase III randomized clinical noninferiority trialXiaoyuan Huang, Ting Fan, Li Li, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Digestive Diseases (Basel, Switzerland)|November 9, 2022
The Role of Mean Nocturnal Baseline Impedance and Post-Reflux Swallow-Induced Peristaltic Wave Index in the Diagnosis and Treatment of Gastroesophageal Reflux DiseaseSiyu Liao, Jiamin Hao, Jing Zhou, et al.
Gastroenterology Research and Practice|June 25, 2016
The Impact of Colonoscopy Quality Control Table on Adenoma Detection RatesBin Deng, Jiehua Zhi, Yaosheng Chen, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 1, 2023
Urolithin C reveals anti-NAFLD potential via AMPK-ferroptosis axis and modulating gut microbiotaJingyuan Xu, Hongyang Tian, Yajun Ji, et al.
Journal of Gastroenterology and Hepatology|December 8, 2022
The interaction between obesity and visceral hypersensitivityWu Yanping, Xuefen Gao, Yizun Cheng, et al.
BMC Infectious Diseases|February 7, 2023
Study on the prediction effect of a combined model of SARIMA and LSTM based on SSA for influenza in Shanxi Province, ChinaZhiyang Zhao, Mengmeng Zhai, Guohua Li, et al.
BMC Infectious Diseases|December 18, 2025
Efficacy, safety and immunogenicity of a recombinant human papillomavirus bivalent (types 16, 18) vaccine in healthy 18-30-year-old Chinese women: a phase III, double-blind, randomized, controlled trialLiwei Shi, Xuefen Gao, Lili Huang, et al.
Vaccine|April 14, 2025
Corrigendum to "Antibody persistence in Chinese toddlers at 1 year and 2 years after two different 4-dose schedules of a novel 13-valent pneumococcal conjugate vaccine (PCV13-TT)" [Vaccine 49 (7) (2025) 126815]Qiang Ye, Hong Li, Zhiqiang Xie, et al.
Vaccine|February 16, 2025
Antibody persistence in Chinese toddlers at 1 year and 2 years after two different 4-dose schedules of a novel 13-valent pneumococcal conjugate vaccine (PCV13-TT)Qiang Ye, Hong Li, Zhiqiang Xie, et al.
Human Vaccines & Immunotherapeutics|May 27, 2026
Comparison of safety and immunogenicity between high-dose and low-dose quadrivalent influenza vaccines in children aged 6-35 months in China: A randomized, double-blind clinical studyXue Guo, Jingyu Li, Xufeng Dong, et al.
Human Vaccines & Immunotherapeutics|June 17, 2022
Safety and immunogenicity of a quadrivalent, inactivated, split-virion influenza vaccine (IIV4-W) in healthy people aged 3-60 years: a phase III randomized clinical noninferiority trialXiaoyuan Huang, Ting Fan, Li Li, et al.
Pageof 1